B1 Non-refereed article in a scientific journal
Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?
Authors: Kimmo Kettunen, Peter Boström, Pekka Taimen
Publisher: ELSEVIER
Publication year: 2020
Journal: European Urology
Journal name in source: EUROPEAN UROLOGY
Journal acronym: EUR UROL
Volume: 77
Issue: 1
First page : E23
Last page: E23
Number of pages: 1
ISSN: 0302-2838
eISSN: 1873-7560
DOI: https://doi.org/10.1016/j.eururo.2019.09.011